about
The human prostanoid DP receptor stimulates mucin secretion in LS174T cellsGastrointestinal Parasites and the Neural Control of Gut FunctionsCrohn's disease in womenHepatitis C Virus Stimulates the Expression of Cyclooxygenase-2 via Oxidative Stress: Role of Prostaglandin E2 in RNA ReplicationClassic NSAID and selective cyclooxygenase (COX)-1 and COX-2 inhibitors in healing of chronic gastric ulcersAspirin effects on gastric epithelial cell proliferation and cytokine expressionDo altering in ornithine decarboxylase activity and gene expression contribute to antiproliferative properties of COX inhibitors?Reduced risk of human lung cancer by selective cyclooxygenase 2 (COX-2) blockade: results of a case control studyCyclooxygenase-2 and cancer treatment: understanding the risk should be worth the rewardLong-term differential changes in mouse intestinal metabolomics after γ and heavy ion radiation exposureDual action of prostaglandin E2 on gastric acid secretion through different EP-receptor subtypes in the ratIdentification and characterization of a cyclooxygenase-like enzyme from Entamoeba histolyticaHelicobacter pylori-induced prostaglandin E(2) synthesis involves activation of cytosolic phospholipase A(2) in epithelial cells.Cytotoxic necrotizing factor from Escherichia coli induces RhoA-dependent expression of the cyclooxygenase-2 Gene.Marked elevations in pro-inflammatory polyunsaturated fatty acid metabolites in females with irritable bowel syndromeReview article: proteinase-activated receptors - novel signals for gastrointestinal pathophysiology.Metabolic profiling of somatic tissues from Monochamus alternatus (Coleoptera: Cerambycidae) reveals effects of irradiation on metabolism.A lay doctor's guide to the inflammatory process in the gastrointestinal tractCorrelation of staining for LKB1 and COX-2 in hamartomatous polyps and carcinomas from patients with Peutz-Jeghers syndrome.Molecular aspects of hepatic carcinogenesis.Curcumin: from ancient medicine to current clinical trials.An evidence-based approach to prescribing NSAIDs in musculoskeletal disease: a Canadian consensus. Canadian NSAID Consensus Participants.Heightened expression of cyclooxygenase-2 and peroxisome proliferator-activated receptor-delta in human endometrial adenocarcinoma.Induction of cyclooxygenase-2 in monocyte/macrophage by mucins secreted from colon cancer cells.Prebiotic treatment reduced preneoplastic lesions through the downregulation of toll like receptor 4 in a chemo-induced carcinogenic model.The menstrual cycle affects rectal sensitivity in patients with irritable bowel syndrome but not healthy volunteersDownregulation of prostaglandin E receptor subtype EP3 during colon cancer developmentRole of cyclooxygenases 1 and 2 in the modulation of neuromuscular functions in the distal colon of humans and mice.Haplotype of prostaglandin synthase 2/cyclooxygenase 2 is involved in the susceptibility to inflammatory bowel disease.EP4 Receptor-Associated Protein in Macrophages Ameliorates Colitis and Colitis-Associated Tumorigenesis.Epidermal growth factor receptor activation induces nuclear targeting of cyclooxygenase-2, basolateral release of prostaglandins, and mitogenesis in polarizing colon cancer cells.Prevention of gastric cancer by Helicobacter pylori eradication.Correlation between expression of cyclooxygenase-2 and angiogenesis in human gastric adenocarcinoma.Prognostic significance of expression of cyclooxygenase-2 and vascular endothelial growth factor in human gastric carcinoma.Heterotopic Gastric Mucosa in the Distal Part of Esophagus in a Teenager: Case Report.Regulation of cyclooxygenase-2 (COX-2) expression in human pancreatic carcinoma cells by the insulin-like growth factor-I receptor (IGF-IR) system.Luminal trypsin may regulate enterocytes through proteinase-activated receptor 2.Cyclooxygenase-2 and its regulation in inflammation.Interaction between cyclooxygenase-2 gene polymorphism and dietary n-6 polyunsaturated fatty acids on colon cancer risk: the Singapore Chinese Health Study.Decreased expression of 15-hydroxyprostaglandin dehydrogenase in gastric carcinomas
P2860
Q24674203-46D2CE0C-0521-4196-99D6-BE8EEEAE1BA2Q26774821-238AE98A-847B-4337-A571-EF87ADBEBEDCQ26851451-D18E2FE0-DD13-4765-80ED-F050BDB92FF5Q27470314-EE72C46D-6DFC-40D2-8806-6A013642461FQ28184249-63BEF760-14DE-46F7-98EC-CBB7671B29F9Q28184269-A8A6130A-F39F-4729-AA60-4E734F1314A2Q28195582-CF9B41D5-740C-432A-A4FD-F9C15E5A038FQ28217572-D8224E12-9C24-499C-B7CE-E04E61F8B0AFQ28274081-2FDF9EA7-CDC0-448D-9608-FADBBFC8A424Q28539199-E1CED398-8B27-4687-B3C5-7E9FBDD2B425Q28577821-426EA257-606B-4D6C-AFA0-A04BD78CBA58Q30449610-057A67B0-DF6D-43E5-A3FB-5EFBEB10014BQ31464711-31149983-0700-469E-A649-40E25B5064ECQ33552763-0798F4DA-3361-4450-B0C9-81F69FE91DF6Q33784540-EC2BDD2B-CC93-451E-A294-A44C81E8F4B0Q33874478-3DE186AF-70F7-403B-BE5D-B77AA64FFBF3Q33907892-025F59AB-AFEF-4128-8EAD-C3242CA5675CQ34048266-2F1F2D1B-94E3-4864-A355-50EE7905E9B2Q34543277-B6B183B8-D5DC-47C5-9286-98608726E63FQ34564963-C639C435-B0A8-4043-9F73-8F1FE432D2B0Q34589151-EA3DBD0C-61A5-4EC6-B119-3A062FE3CAEAQ34712405-9648744E-FB74-49CC-9C94-3740E53A43DAQ34786102-A958FD1A-1977-421E-A411-0C6374069FB6Q34808316-A72E22C9-6C95-429E-AAE1-C5356BA577ADQ35082860-E9FEB707-413F-41E8-B1BC-2513AF6E7EF0Q35594502-0BE6073C-133A-485E-9582-E56ACCBFB9D1Q35596716-891232F9-C65B-488C-A653-0860E7D9CD9CQ35597403-DF528D33-C3B1-4DC5-A75B-791267DF0C61Q35621619-7DA79880-FCDD-423D-9455-AFF602B5D619Q35800476-A2DC5345-29F0-4CF9-B622-0A49885698FCQ35959962-82FED076-D595-48F4-8804-0C24A8652714Q36090021-AE9EB37D-B790-46AB-85BD-DDA2B48A14DBQ36178617-09663F8A-8752-46D1-B481-E910ACF0DC12Q36190616-43D7F03B-A230-453C-B336-AEE684B31365Q36206912-C91BDFA0-AC61-403B-9285-5F8482E0ED26Q36287335-8C60082F-D445-40C7-93AA-C546D5175E2BQ36565261-C7AA4A44-066A-44DA-B04C-ED625748635FQ36628126-2F7385D3-D10D-484E-B013-3CBB60A5978DQ36695052-FC9B5733-3CFC-448F-9834-0669E06233B4Q37065177-BF97678D-0C29-4B84-8C38-EB6EBC3D2DC2
P2860
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Eicosanoids and the gastrointestinal tract.
@en
type
label
Eicosanoids and the gastrointestinal tract.
@en
prefLabel
Eicosanoids and the gastrointestinal tract.
@en
P1433
P1476
Eicosanoids and the gastrointestinal tract.
@en
P2093
Eberhart CE
P304
P356
10.1016/0016-5085(95)90296-1
P407
P577
1995-07-01T00:00:00Z